Efficacy and safety of rituximab in autoimmune and microangiopathic hemolytic anemia: a systematic review and meta-analysis

Efficacy and safety of rituximab in autoimmune and microangiopathic hemolytic anemia: a systematic review and meta-analysis

Show other versions (1)

Abstract Background The efficacy and safety of rituximab (RTX) on hemolytic anemia (HA) is unknown. Therefore we retrospectively analyze the efficacy and safety of RTX in autoimmune hemolytic anemia (AIHA) and microangiopathic hemolytic anemia (MAHA) from the previous literature. Methods Data in cli...

Full description

Bibliographic Details
Main Authors: Shih-Hsuan Chao, Yuh-Lih Chang, Jiin-Cherng Yen, Hsien-Tzung Liao, Tsai-Hung Wu, Chia-Li Yu, Chang-Youh Tsai, Yueh-Ching Chou
Format: Article
Language:English
Published: BMC 2020-04-01
Series:Experimental Hematology & Oncology
Online Access:http://link.springer.com/article/10.1186/s40164-020-00163-5

Internet

http://link.springer.com/article/10.1186/s40164-020-00163-5

Similar Items